Cargando…

The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies

OBJECTIVE: This study was performed to evaluate the clinical performance of APTIMA human papillomavirus (AHPV) assay and Hybrid Capture 2 (HC2) assay in screening for cervical disease, especially in women with atypical squamous cell of undetermined significance (ASC-US) and low-grade squamous intrae...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yanli, You, Ke, Geng, Li, Qiao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195298/ https://www.ncbi.nlm.nih.gov/pubmed/25142625 http://dx.doi.org/10.3802/jgo.2014.25.4.287

Ejemplares similares

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Evaluation of Aptima Zika Virus Assay
por: Ren, Ping, et al.
Publicado: (2017)

Genotype Distribution of Human Papillomaviruses in Japanese Women with Abnormal Cervical Cytology
por: Kondo, Kazunari, et al.
Publicado: (2012)

Association of abnormal cervical cytology with coinfection of human papillomavirus and Chlamydia trachomatis
por: Madaan, Nisha, et al.
Publicado: (2019)

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
por: Iftner, Thomas, et al.
Publicado: (2019)

Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy
por: Yan, Lei, et al.
Publicado: (2023)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study
por: Schwebke, Jane R., et al.
Publicado: (2020)

High-risk Human Papillomavirus Testing for Triage of Women with Previous Cytological Abnormalities from the Vale do Ribeira Region
por: Lorente, Sandra, et al.
Publicado: (2020)

16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2019)

The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus
por: Dames, Dionne N, et al.
Publicado: (2009)

Prevalence and Molecular Epidemiology of Human Papillomavirus Infection in Italian Women with Cervical Cytological Abnormalities
por: Meloni, Angelo, et al.
Publicado: (2014)

Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities
por: Zoa Assoumou, Samira, et al.
Publicado: (2016)

Molecular Epidemiology of Human Papillomavirus Infection Among Chinese Women With Cervical Cytological Abnormalities
por: Wong, Eliza Lai-Yi, et al.
Publicado: (2022)

Prevalence of Abnormal Anal Cytology in Women with Abnormal Cervical Cytology
por: Inthasorn, Perapong, et al.
Publicado: (2021)

Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China
por: Wang, Jing, et al.
Publicado: (2019)

Human papillomavirus and Chlamydia trachomatis in oral and genital mucosa of women with normal and abnormal cervical cytology
por: Mosmann, J. P., et al.
Publicado: (2021)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study
por: Cobo, Fernando, et al.
Publicado: (2009)

Triage human papillomavirus testing for cytology-based cervical screening in women of different ages in primary hospitals: A retrospective clinical study
por: Zhang, Yuan-yuan, et al.
Publicado: (2020)

Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation
por: Weston, Georgie, et al.
Publicado: (2020)

Value of human papillomavirus typing for detection of anal cytological abnormalities
por: Maia, Livia Bravo, et al.
Publicado: (2013)

Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.
por: Herrington, C. S., et al.
Publicado: (1995)

Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
por: Figueiredo, Daniel, et al.
Publicado: (2023)

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening
por: Han, Qin, et al.
Publicado: (2020)

The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China
por: Pan, Diling, et al.
Publicado: (2020)

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology
por: Termrungruanglert, Wichai, et al.
Publicado: (2018)

APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database
por: Khader, Samer N., et al.
Publicado: (2010)

Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
por: de Salazar, Adolfo, et al.
Publicado: (2019)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test
por: Rijkaart, D C, et al.
Publicado: (2010)

Reflex cytology for triage of high‐risk human papillomavirus positive self‐sampled material in cervical cancer screening: a prospective cohort study
por: Loopik, DL, et al.
Publicado: (2020)

Human Papillomavirus Infection and Anxiety: Analyses in Women with Low-Grade Cervical Cytological Abnormalities Unaware of Their Infection Status
por: Johnson, Candice Y., et al.
Publicado: (2011)

Utilization of Human Papillomavirus DNA Detection for Cervical Cancer Screening in Women Presenting With Abnormal Cytology in Lokoja, Nigeria
por: Kolawole, Olatunji, et al.
Publicado: (2015)

Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark – the SHADE
por: Thorsteinsson, Kristina, et al.
Publicado: (2016)

Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology
por: Buick, Catriona, et al.
Publicado: (2021)

Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay
por: Manak, Mark M., et al.
Publicado: (2017)

A PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus
por: Wang, Yumei, et al.
Publicado: (2014)

Performance Evaluation of the Aptima Assays in Comparison with the cobas 6800 Assays for the Detection of HIV-1, HBV, and HCV in Clinical Samples
por: Park, Younhee, et al.
Publicado: (2022)

Detection of abnormal cervical cytology in Papanicolaou smears
por: Bal, Manjit Singh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4ni2qk3vu817pu7sv89umc6h8c